Skip to content
About
Overview
About overview
Our strategy
Our leadership
How we’re funded
Our history
Our science
Overview
Our science overview
Antibody development
Clinical development
Data science
Diagnostics development
Small molecule drug discovery
Work with us
Overview
Work with us overview
Funding, projects and partnerships
Focus areas
Overview
Focus areas overview
Motor Neuron Disease & Rare Dementias
Chronic & Rare Respiratory
Rare Disease
Childhood Cancer
Global Health
Ventures
Overview
Ventures overview
Careers
Overview
Careers overview
Benefits and rewards
Early careers
Current vacancies
News and events
News
Events
Contact us
Search
Toggle Menu
News
News
Events
Filter
News types
Articles
Blogs
News releases
Patient stories
Topics
Data science
Company updates
Motor neuron disease & rare dementias
Chronic & rare respiratory
Global health
Rare disease
Childhood cancer
Neurodegeneration
Technology transfer
Our science
Ventures funding
2 October 2006
MRCT to humanize antibody to treat AD
Read more
: MRCT to humanize antibody to treat AD
6 June 2006
TYSABRI gains market approval
Read more
: TYSABRI gains market approval
6 March 2006
MRCT and Chinese National Centre collaborate on malaria
Read more
: MRCT and Chinese National Centre collaborate on malaria
5 December 2005
Therapeutic Antibody Group starts
Read more
: Therapeutic Antibody Group starts
26 October 2005
MRC to receive over USD200m
Read more
: MRC to receive over USD200m
Previous page
1
…
35
36
37
Want the latest news from us?
Sign up for updates
Contact our media team
Close Modal
